Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutation

Clinical and Applied Thrombosis/Hemostasis

Volumn 7, Issue 1, 2001, Pages 72-74

  Vayá, Amparo ^a   Todolí, Jose ^a   Ricart, Jose ^a   Estellés, Amparo ^b   Mira, Yolanda ^a   Villa, Piedad ^a   Calabuig, Jose Ramon ^b   Aznar, Justo ^a  

^a Department of Clinical Pathology ^*  (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Factor V Leiden; Prothrombin G20210A; Thrombophilia; Upper extremity deep vein thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ADULT; ARM; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; GENETIC DISORDER; HETEROZYGOSITY; HUMAN; INDWELLING CATHETER; INHERITANCE; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA;

ADULT; ARM; CATHETERS, INDWELLING; FACTOR V; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; PEDIGREE; POINT MUTATION; PROTHROMBIN; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0035146790     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960100700114     Document Type: Article

References (12)

1. Upper-extremity deep vein thrombosis. Risk factors diagnosis and complications
2. Low prevalence of thrombophilic coagulation defects in patients with deep vein thrombosis of the upper limbs
3. Risk factors for deep venous thrombosis of the upper extremities
4. Hypercoagulable states in primary upper-extremity deep vein thrombosis
5. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prohrombin gene
6. Coexistence of factor V Leiden and factor II A20210 mutations and recurrent venous thromboembolism
7. Geographic distribution of the 20210G to A prothrombin variant
8. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population
9. Venous thromboembolism at a young age in a brother and sister with coinheritance of homozygous 20210A/A prothrombin mutation and heterozygous 16916/A factor V Leiden mutation
10. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
11. Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: Results from a large family
12. The risk of recurrent deep venous thrombosis